| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/29/2008 | CA2237721C Antineoplastic peptides |
| 01/24/2008 | WO2008010831A1 An oxidation process for the preparation of n-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl]-3-{n-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0] hexane-2-carboxamide and related compounds |
| 01/24/2008 | WO2008010218A1 Peptides derived from human histone h2a and methods of use thereof |
| 01/24/2008 | WO2008009942A1 Heteroaromatic-based peptide macrocycles as g-quadruplex ligands |
| 01/24/2008 | WO2007139921A3 N-oxides of kappa opioid receptor peptides |
| 01/24/2008 | WO2007137080A3 Compounds and compositions as channel activating protease inhibitors |
| 01/24/2008 | US20080021198 Modulators of protein phosphatase 2A and PP2A methyl esterase |
| 01/24/2008 | US20080021196 Inhibitors of memapsin 2 and use thereof |
| 01/24/2008 | US20080021014 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 01/24/2008 | CA2628738A1 An oxidation process for the preparation of n-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl]-3-{n-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0] hexane-2-carboxamide and related compounds |
| 01/23/2008 | EP1881002A1 HCV NS-3 serine protease inhibitors |
| 01/23/2008 | EP1881001A1 HCV NS-3 serine protease inhibitors |
| 01/23/2008 | EP1879910A2 Tripeptides as hepatitis c virus inhibitors |
| 01/23/2008 | EP1879604A2 Pif tetrapeptides |
| 01/23/2008 | EP1786831A4 Alanine 2, 3 aminomutases |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | CN101111513A Glycopeptide antibiotic monomer derivative |
| 01/23/2008 | CN101111512A Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/23/2008 | CN101108876A Method for preparing S- protection glutathione by adopting complexation common protection |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN100363382C Endomorphin analog and its preparing method |
| 01/23/2008 | CN100363380C Liquid phase synthetic method for endomorphine -1 and endomorphine -2 |
| 01/23/2008 | CN100363355C Method for preparing alkyloxy furnanone derivatives, compounds obtained by said method and use of said compounds |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7321045 Vitronectin receptor antagonist pharmaceuticals |
| 01/22/2008 | US7321027 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | US7320960 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/22/2008 | US7320888 Submergence-induced protein-like factors |
| 01/22/2008 | US7320867 Linker compound, ligand, and producing method thereof |
| 01/22/2008 | CA2312431C New compounds |
| 01/17/2008 | WO2008008732A2 Substituted aminopyridines as fluorescent reporters for amide hydrolases |
| 01/17/2008 | WO2008008502A1 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 01/17/2008 | WO2007134127A3 Agents for imaging apoptosis |
| 01/17/2008 | WO2007064759A3 Inhibiting tumour cell invasion, metastasis and angiogenesis through targetting legumain |
| 01/17/2008 | WO2007005838A3 Hcv inhibitors |
| 01/17/2008 | WO2006105490A3 Compositions and methods for treating diseases associated with phlpp |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | CA2657665A1 Method and compositions for treating stroke with fever |
| 01/17/2008 | CA2657618A1 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 01/16/2008 | EP1878740A1 A process for the preparation of delapril |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1877422A1 Green tea polyphenol alpha secretase enhancers and methods of use |
| 01/16/2008 | EP1877421A2 Single-chain antibody with cleavable linker |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1107969B1 Collections of compounds |
| 01/16/2008 | CN101107263A Inhibition of sweat malodour |
| 01/16/2008 | CN100362109C Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 01/16/2008 | CN100361987C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319010 Detection and treatment of cancers of the colon |
| 01/15/2008 | CA2314122C Sweetener composition |
| 01/15/2008 | CA2145527C Tissue protective and regenerative compositions |
| 01/10/2008 | WO2007121147A3 Disheveled pdz modulators |
| 01/10/2008 | WO2007109620A3 Macrocyclic peptides and methods for making and using them |
| 01/10/2008 | US20080009448 Peptide Derivative |
| 01/10/2008 | US20080009435 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1876169A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 01/09/2008 | EP1874800A1 Diagnostic and therapeutic agents |
| 01/09/2008 | EP1874329A1 Blood pressure lowering protein hydrolysates |
| 01/09/2008 | EP1874129A1 Peptides having an ace inhibiting effect |
| 01/09/2008 | EP1874128A1 Peptides having an ace inhibiting effect |
| 01/09/2008 | EP1527086B1 Compounds binding to p-selectin |
| 01/09/2008 | EP1460084B1 Novel peptide sy |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | CN101100483A Analogue of muramyl dipeptide |
| 01/09/2008 | CN100360564C Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 01/09/2008 | CN100360552C Method for synthesizing bursa of Fabricius bursin |
| 01/08/2008 | US7317129 Chemical synthesis of reagents for peptide coupling |
| 01/08/2008 | US7317000 Glucose-dependent insulins |
| 01/08/2008 | US7316996 For stimulating macrophages, for stimulating antibody synthesis, for combating infection, as an immunostimulant, in particular in relation to tumors, for preventing and treating septicaemic shock, for wound healing and as an adjuvant for vaccines |
| 01/08/2008 | CA2315206C Granular sweetener |
| 01/03/2008 | WO2008003079A1 Compositions and methods pertaining to guanylation of pna oligomers |
| 01/03/2008 | WO2008001837A1 Method for purification of oligopeptide |
| 01/03/2008 | WO2008001175A2 Dipeptide compounds containing d-histidine |
| 01/03/2008 | WO2008001174A1 Peptide derivatives with therapeutic activity |
| 01/03/2008 | WO2008000641A1 Pseudo proline dipeptides |
| 01/03/2008 | WO2007072212A3 Synthetic ligands able to bind ochratoxin a and uses thereof |
| 01/03/2008 | WO2006113942A3 Method of inhibiting cathepsin activity |
| 01/03/2008 | WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| 01/03/2008 | US20080004429 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 01/03/2008 | US20080003178 PIF tetrapeptides |
| 01/03/2008 | DE102006029830A1 Growing of deuterated alanine doped triglycine sulfate monocrystals from a solution for night vision device, comprises arranging a crystal holder in a chamber of a device and pumping the solution in a circulation with the chamber |
| 01/03/2008 | CA2654914A1 Pseudo proline dipeptides |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | CN101095675A Dipeptidyl peptidase IV effectors |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314867 Pharmaceutical composition comprising a retro-iverso isomer peptide |
| 01/01/2008 | US7314866 designing a peptide or chemical to mimic the Bax-suppressing function of VPMLKE, VPMLK, PMLKE or PMLK; apoptosis resistance |
| 01/01/2008 | US7314862 Antitumor agent |
| 12/27/2007 | WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition |
| 12/27/2007 | WO2007148847A1 Stabilized vitamin c derivatives having a peptide molecule, preparation method thereof, and composition containing the same |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148804A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148803A1 Composition capable of promoting the production of hyaluronic acid |